tradingkey.logo
tradingkey.logo
検索

Collplant Biotechnologies Ltd

CLGN
ウォッチリストに追加
0.340USD
-0.009-2.63%
終値 07/02, 13:00ET15分遅れの株価
4.36M時価総額
損失額直近12ヶ月PER

詳細情報 Collplant Biotechnologies Ltd 企業名

CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Collplant Biotechnologies Ltdの企業情報

企業コードCLGN
会社名Collplant Biotechnologies Ltd
上場日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)
従業員数57
証券種類Ordinary Share
決算期末Sep 01
本社所在地4 Oppenheimer Street
都市REHOVOT
証券取引所NASDAQ OMX - NASDAQ BASIC
Israel
郵便番号7670104
電話番号972732325600
ウェブサイトhttps://www.collplant.com
企業コードCLGN
上場日Sep 01, 1993
最高経営責任者「CEO」Rotem (Eran)

Collplant Biotechnologies Ltdの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Founder, Chief Scientist
Founder, Chief Scientist
--
--
Dr. Nadav Orr
Dr. Nadav Orr
Vice President - Research & Development
Vice President - Research & Development
--
--
Dr. Ilana Belzer, Ph.D.
Dr. Ilana Belzer, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Gili Hart
Dr. Gili Hart
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Yehiel Tal
Mr. Yehiel Tal
Chief Executive Officer
Chief Executive Officer
56.14K
+44.53%
Mr. Eran Rotem, CPA
Mr. Eran Rotem, CPA
Deputy Chief Executive Officer, Chief Financial Officer
Deputy Chief Executive Officer, Chief Financial Officer
26.25K
--
Dr. Philippe David Bensimon
Dr. Philippe David Bensimon
Vice President - Regulatory Affairs and Quality Assurance
Vice President - Regulatory Affairs and Quality Assurance
15.13K
+86.78%
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
3.13K
--
Mr. Joseph Zarzewsky
Mr. Joseph Zarzewsky
Independent Director
Independent Director
3.13K
--
Ms. Alisa Lask
Ms. Alisa Lask
Independent Director
Independent Director
3.13K
--

よくある質問

Collplant Biotechnologies Ltdの上位5名の株主は誰ですか?

Collplant Biotechnologies Ltdの上位5名の株主は以下のとおりです。Mr. Yehiel Tal

Collplant Biotechnologies Ltd(CLGN)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Collplant Biotechnologies Ltdの株式を保有している機関は35社あり、保有株式の総市場価値は約1.89Mで、全体の13.14%を占めています。2025Q4と比較して、機関の持ち株は-218892.00増加しています。

Collplant Biotechnologies Ltdの最大の収益源は何ですか?

2026Q1において、Revenues from licensing agreement部門がCollplant Biotechnologies Ltdにとって最大の収益を生み出しており、その金額は2.00Mで、全収益の84.35%を占めています。